Nanoemulsion in Management of Colorectal Cancer

Version	Summary	Created by	Modification	Content Size	Created at	Operation
1		Bhupendra G Prajapati	--	2701	2023-08-11 11:59:39	\|
2	format change	Peter Tang	Meta information modification	2701	2023-08-14 03:00:47	\|

This entry is adapted from the peer-reviewed paper 10.3390/nanomanufacturing3020010

The second most significant cause of cancer-related mortality and morbidity in the United States is colorectal cancer (CRC), the third most diagnosed malignancy. People over 50 have an increased risk of CRC everywhere in the world. Genetic and environmental risk factors significantly influence CRC development. Early detection is critical in the treatment and prevention of CRC. The population’s incidence rate of CRC is reduced by screening techniques and medicines, although recurrence of the disease may result from the cancer’s ability to spread locally. Nanotechnology is crucial for cancer treatment because it allows for the delivery of targeted chemotherapies to cancer cells directly and with greater therapeutic potency. Nanoemulsions have broad application in pharmaceutics, cosmetics, and food; their outstanding properties include enhanced dispersion of active hydrophobic components, small size, high surface area per unit volume, and improved absorption in cancer treatment.

nanoemulsion surfactant stability colon cancer high energy shearing

1. Introduction

The dispersion phase and the continuous phase are two immiscible phases that make up an emulsion. In the beginning, Schulman coined the phrase “microemulsion”. After more investigation into microemulsion, researchers discovered a kinetically stable emulsion known as nanoemulsion ^[1]. The definition of a nanoemulsion by the International Union of Pure and Applied Chemistry (IUPAC) is a dispersion made up of water, oil, and surfactant with a dispersed domain diameter and is isotropic and thermodynamically stable. In practice, the nanoscale emulsion is created using mechanical force. Nanoemulsions are emulsions that are smaller than tens to hundreds of nanometers in size. As the system strives to reach a state of minimal Gibbs free energy, surfactants work at the interface between the two immiscible phases to reduce surface tension and stabilize the emulsion ^[2]. Because they can quickly solubilize hydrophobic pharmaceuticals and lessen severe side effects, nanoemulsions have much potential ^[3].

2. Types, Composition, and Characterization of the Nanoemulsion System

Emulsions are a mixture of two or more phases, one of which is hydrophilic and the other hydrophobic, scattered throughout each other. When tiny oil droplets are scattered throughout water, the emulsion is called an oil-in-water (O/W) emulsion ^[4]. The homogenization method employed during the creation of nanoemulsions and traditional O/W emulsions determines the droplet sizes of the final products ^[4]^[5]. When water droplets are mixed with oil, water-in-oil (W/O) emulsions are created. In microreactors, W/O nanoemulsions regulate nanoparticle formation, including Cd [cadmium] nanoparticles and titania–silica nanoparticles ^[6]^[7]. As reaction media, different W/O emulsions are employed to produce ceramic nanoparticles. W/O emulsions are used in the pharmaceutical business as adjuvants for vaccines containing uncommon antigens, such as synthetic peptides, DNA, or recombinant proteins. However, by enclosing an emulsion within an emulsion, resulting in oil-in-water-in-oil (O/W/O) or water-in-oil-in-water (W/O/W) emulsions, these straightforward systems can be made more complex.

Double emulsions are often created in two steps: An initial internal emulsion is created, and then a second emulsion is created to cover the initial emulsion. Double emulsions present difficulties in their formation and stabilization, including the need to preserve the integrity of the first emulsion when creating the second one, the need for both a hydrophilic surfactant and a lipophilic surfactant to stabilize each oil–water interface, and a higher propensity for coalescence and degradation because of diffusion between each phase ^[8]. Microfluidic devices have sparked interest in studying uniform double emulsions for use in food science and as templates for particle synthesis or microreactors ^[9]^[10]. In contrast to most emulsions, in which the internal phase only accounts for a negligible fraction (10%) of the overall emulsion volume, high internal phase emulsions contain an internal phase higher than 74% of the total emulsion volume ^[11].

Pickering emulsions are oil-in-water or water-in-oil emulsions in which minute particles operate as a steric barrier to coalescence at the oil–water interface as opposed to small molecules that alter the interfacial tension ^[12]. Stabilizing particles by moistening pickering emulsions with both emulsion phases is possible. This property makes them more effective than conventional surfactants at increasing emulsion stability by allowing them to sit at the oil–water interface ^[13]. Pickering emulsions have been investigated as an alternative to small molecule surfactants for drug delivery applications because of their increased stability and biocompatibility.

3. Nanoemulsion for Colorectal Cancer Delivery

A large fraction of cancer-related deaths worldwide is caused by colon cancer. Treatment options for colon cancer typically include surgery, herbal remedies, immunotherapy, radiation, and chemotherapy. Since nanotechnology has been proven effective for treating cancer, researchers have concentrated their efforts on this area. The most prevalent types of nanoemulsions for different types of cancer are summarized in Table 1, a summary of some recent nanoemulsions developed and applications for colorectal and other cancer.

Worldwide, colon cancer is responsible for a disproportionate number of cancer deaths. This section classifies the various subtypes of colon cancer, including familial adenomatous polyposis, hereditary nonpolyposis colon cancer, cancer that develops independently, and cancer linked to colitis ^[14]. Surgery is the primary treatment option for colon cancer; other possibilities include chemotherapy, radiation therapy, immunotherapy, and alternative medicine. However, survival rates due to metastasis and reoccurrence continue to decline for around five years after surgery, suggesting that the tumor is not the primary cause of death ^[15]. Tomatoes contain lycopene, which possesses several potential health benefits if it were more stable and bioavailable, including protection from chronic diseases, antiproliferation activity against leukemia and colon cancer cells, and the induction of cell cycle arrest in some tumor cells ^[16]^[17]^[18]. In the described research, a nanoemulsion was created using lycopene to address the issue.

Additionally, gold nanoparticles could be encased in a nanoemulsion formulation (AN). Rather than merely serving as a medication carrier, AN could also comprise cell receptor ligands to facilitate precise cell targeting ^[19]. Combining lycopene-derived molecules with liposomes, polymeric substances, or other lipid-based assemblies can mitigate this effect ^[20]. In this formulation, Tween 80^® serves as the emulsifier, oil containing lycopene is the oil phase, and an aqueous AN solution is the water phase. The HT-29 human colon cancer cell line is suitable for its application. The formulation’s effectiveness was demonstrated by testing the effects of AN alone, lycopene alone, and combining the two on a cell line ^[21]. Using a nanoemulsion preparation method, the author of this study investigated the anticancer and apoptotic effects of S. aromaticum L. bud essential oil (SABE) on human HT-29 colon cancer cells. Apoptosis (Cas3 overexpression and higher SubG1 peaks) and cell death (reduced HT-29 viability) were seen in response to a wavelength of 131.2 nm in this study ^[17]. In a phase inversion process, Sabna Kotta created a nanoemulsion of resveratrol (low energy technique). Grapes, berries, and other fruits contain resveratrol, a polyphenolic phytoalexin. Human colorectal cancer cell lines (HCT-166) were employed to test the antiproliferative effects of a resveratrol nanoemulsion. The research also showed that nanoemulsion had a concentration-dependent killing effect on HCT-166 colon cancer cells ^[22].

The author investigated the Lycium barbarum L. plant’s carotenoid extracts. Nine carotenoids, including neoxanthin, all-trans-zeaxanthin and its cis-isomers, all-trans—cryptoxanthin), all-trans—carotene and its cis-isomers, were analyzed by high-performance liquid chromatography-mass spectrometry with the highest extraction yield achieved using a solvent system of hexane–ethanol–acetone (1:1:1); the IC50 values for inhibiting the development of HT-29 colon cancer cells were reported to be 4.5 and 4.9 µg mL⁻¹ for carotenoid extracts and their nanoemulsion, respectively. G2/M phase arrest was caused by the extract and nanoemulsion, which also raised p53 and p21 expression and lowered CDK2, CDK1, cyclin A, and cyclin B expression ^[23].

The Spirulina platensis microalgae were used to prepare cerium oxide nanoparticles (CeO2-NPs) by Seyedeh and Asoodeh. Additionally, the ultrasonic emulsification process created nanoemulsions (CeO2-NE) by encapsulating cerium oxide nanoparticles (CeO2-NPs) inside nanoporous polymer shells. Quantitative PCR analysis of apoptotic and antioxidant-related gene expression in HT-29 cells treated with CeO2-NE revealed that CeO2-NE had a more potent effect on anticancer activities. Apoptosis was validated by finding overexpressed caspase-3, caspase-8, and caspase-9 in CeO2-NE. A correlation was found between the overexpression of superoxide dismutase and the redox potential of CeO2-NE in HT-29 colon cells ^[24].

To test the cytotoxic activity of Carum carvi oil nanoemulsions (CCONE), the researchers used the MTT assay on human HT29 colon cells. They found that increasing the nanoemulsion (CCONE) concentration significantly elevated caspase3 gene expression. These data demonstrate that CCONE promotes apoptosis in human colon cancer cells with minimal toxicity. However, further research is required both in vivo and in vitro ^[25].

Due to its serious adverse effects, oxaliplatin (Oxa) has had a limited therapeutic role in the management of colon cancer. Many distinct mutational patterns of p53 are seen in colon cancer, affecting the effectiveness of chemotherapeutic drugs such as Oxa. For this reason, it is crucial to discover an alternate therapeutic strategy that mitigates the side effects of Oxa but also enhances its efficacy in the fight against colon malignancies. In this study, Al-Otaibi and Al-Motwaa created a nanoemulsion of Teucrium polium L. essential oil (TPO-NANO). They tested its efficacy in treating colon cancer cells that differed in their sensitivity to the chemotherapeutic agent oxaliplatin based on their p53 status (HCT116 wild-type and HT-29 mutant-type). According to results from an anticancer screen, Oxa+TPO-NANO inhibited the development of both p53 wild-type HCT116 and p53 mutant-type HT-29 colon cancer cells and generated more morphological changes and apoptotic cell death than did Oxa-NS alone. Put another way, the essential oil nanoemulsion of Teucrium polium L. has a synergistic anticancer impact ^[26].

The antitumor activity of the combination formulas of DOX and SIM, either loaded in water (DOX-SIM-Solution) or nanoemulsions (N.E.s) (DOX-SIM-NE), was evaluated in a Swiss albino mouse model of Ehrlich ascites carcinoma. The study showed that incorporating SIM into the DOX-loaded-NE formulation remarkably improved its efficiency and reduced adverse effects ^[27]. Moreover, resiquimod-fortified nanoemulsion demonstrated significant antitumor immunity by TLR7/8 and TLR9 activations with induced PD-L1 upregulation in tumors. In addition, a pronounced immunostimulatory effect against polarized macrophage cells treated with test and control nanoemulsions was displayed ^[28]. Another safety evaluation of quercetin nanoemulsions on Wistar rat’s organ histopathology, including the liver, spleen, kidney, heart, and brain, indicated insignificant signs of atrophy, hyperplasia, necrosis, or inflammations ^[29]. The recent patents on nanoemulsions for cancer treatment are tabulated in Table 2.

Table 1. Summary of some recent nanoemulsions developed and applications for colorectal and other cancer.

Nanoemulsion Constituents	Active Compound	Production Technique	Type of Cancer	References
Carotenoid; nanoemulsions; CapryolTM 90; Transcutol^®HP; Tween 80	Carotenoid extract from Lycium barbarism	Ultrasonication method	Colon cancer	^[21]
Nanoemulsions carrying gold nanoparticles Tween 80	Lycopene	Ultrasonication method	Colon cancer	^[23]
Transcutol-HP (surfactant), IPA (cosurfactant), water (aqueous phase), and castor oil (oil phase)	5-Fluorouracil (5-FU)	Oil phase titration method (PIT)	Colon cancer (HT-29)	^[30]
Tween 80 (T80) and propylene glycol (P.G.) as surfactant and cosurfactant	Teucrium polium L. essential oil	High-pressure homogenization method	Colon cancer HCT116 wild-type and HT-29 mutant-type	^[26]
Capryol 90, Surfactant (Tween 20) m andcosurfactant (PEG 400)	Resveratrol	Phase inversion composition	Colorectal cancer	^[31]
DSPE-PEG₂₀₀₀	Irinotecan	Phase inversion composition	Colorectal cancer	^[32]
Salvia (SAL) essential oil	Ifosfamide	Oil phase titration method (PIT)	Colorectal cancer	^[33]
Tween 80 as a surfactant, tocopheryl polyethylene glycol 1000 succinate (TPGS) as a cosurfactant, and Kollisolv MCT 70 as the oil phase	Curcumin	Oil phase titration method (PIT)	Pituitary and colon cancer	^[34]
Anethole (57.9%), terpinolene (13.8%), G-terpinene (8.1%), myrcene (6.8%), hexyl butyrate (5.2%), octylbu-tanoate (4.5%), and octyl acetate (3.7%)	Heracleum persicum	Phase inversion composition	Breast cancer	^[35]
linalyl acetate, limonene, and α-terpineol	Citrus aurantium L.	Phase inversion composition	Human lung (A549 cells)	^[36]

Table 2. Recent patents on nanoemulsions for cancer treatment.

Year	Patented Nanoemulsion	Patent No.	Used for	References
2019	An oil-in-water nanoemulsion (N.E.) drug delivery that encapsulates omega-3 polyunsaturated fatty acid (PUFA)-taxoid	US10206875	Anticancer	^[37]
2021	A nanoemulsion consisting of an oil phase, a surfactant, and an aqueous component and an aqueous phase containing a water-soluble active ingredient, a polysaccharide, and hyaluronic acid	US11103600	Anticancer	^[38]
2022	A nanoemulsion prepared using oxysterol or oxysterol-like compound	US11332494	Anticancer	^[39]
2022	A water-in-oil nanoemulsion containing an oil phase ingredient, a surfactant, and an aqueous phase ingredient which includes a cancer cell fluorescence-inducing substance and a polysaccharide that targets cancer cells, and it is dispersed in water to remove the oil phase ingredient, resulting in the formation of the nanocarrier, which also contains the aqueous phase ingredient	US11298428	Anticancer	^[40]
2022	The O/W nanoemulsion that contains 8–12% w/v essential oil, 1–5% w/v polysorbate 80 surfactants, 2–6% w/v glyceryl citrate/lactate/linoleate/oleate co-surfactant, and 1–5% w/v glycerol monocaprylate, type I, wherein a ratio of the surfactant and cosurfactant to essential oil is from 1:1.1 to 1:1.6	US11364199	Transdermal delivery	^[41]
2022	Ionic liquid-based nanoemulsion consisting of hydrophobic ionic liquid comprises a dication comprising two monocationic groups linked by a bridging group wherein the bridging group provides an at least partially hydrophobic character	US11464738	Hydrophobic drug delivery	^[42]
2022	An oil-in-water nanoemulsion that contains clobetasol, one or more oil components, one or more surfactants, and one or more pharmaceutically acceptable excipients or carriers, as well as a continuous aqueous phase and dispersed oil droplets	US10857160	Prophylaxis or treatment of inflammatory diseases or conditions	^[43]
2022	A fluorocarbon nanoemulsion prepared by using perfluorohexane and one or more surfactants selected from perfluoro-n-hexyl-oligo ethylene oxy-alcohols	US11304899	For enhanced oxygen delivery	^[44]
2022	An oil-in-water emulsion consisting of an internal oil phase includes lauric oil, an external aqueous phase (water or glycerol), and surfactants, preferably anionic surfactants, amphoteric surfactants	US11266580		^[45]
2022	An aqueous, transparent nanoemulsion composition includes at least two different bilayer water-core liposome components and at least one monolayer surfactant-bound particle component	US11304900	For delivering oil- and water-soluble components of a vitamin supplement	^[46]
2022	An injection fluid nanoemulsion is prepared by dispersing the oil phase in an aqueous phase, and the formed oil nanodroplets that have a diameter of from 20–1000 nanometers and dispersion of the oil phase in the aqueous phase stabilized by surfactant and nonsuperparamagnetic magnetic nanoparticles encapsulated in the formed oil nanodroplets	US11506049	-	^[47]
2022	The nanoemulsion composition consists of a lipid nanoparticle with an inorganic nanoparticle-based hydrophobic core	US11534497	For delivering RNA	^[48]
2022	A nanoemulsion composition comprising nanoemulsion particles that contain a hydrophobic core (mixture of liquid oil and one or more inorganic nanoparticles or one or more lipids, such as a cationic lipid) with one or more surfactants and a bioactive agent complexed with the nanoemulsion particles	US11376335	For delivering RNA	^[49]

4. Ongoing Clinical Trials on Nanoemulsions for Cancer Therapy

Nanoemulsions can be an excellent alternative to other anticancer medication to ensure better cancer treatment. There are just a few trials reported on nanoemulsions. In an ongoing clinical experiment, nanoemulsions have been employed for photodynamic treatment on superficial basal carcinoma cells. Three photosensitizers were compared using a randomized, prospective, double-blind approach (phase 2). Methyl aminolevulinate (MAL/Metvix^®), hexyl amino levulinate (HAL/Hexvix^®), and aminolevulinic acid nanoemulsion (BF-200 ALA/Ameluz^®) was used to treat basal cell carcinomas.

Curcumin has been extensively researched for cancer, as was previously mentioned. Curcumin is a naturally occurring polyphenolic substance isolated from the rhizomes of Curcuma longa. It exhibits various biological properties, including antioxidant and anti-inflammatory properties ^[50]. No clinical study specifically designed to treat cancer has been conducted yet. Instead, a randomized, double-blinded phase one controlled research trial (ClinicalTrial.gov ID: NCT03865992) evaluated curcumin-loaded nanoemulsions.

Curcumin nanoemulsions have been the subject of a second clinical trial reported to treat obese women at a high risk of breast cancer (ClinicalTrial.gov ID: NCT01975363). It was a randomized pilot trial that examined the safety, tolerability, and compliance of various doses (50 or 100 mg) of nanoemulsion curcumin in overweight women with a greater chance of developing breast cancer. Curcumin’s anti-inflammatory properties in breast tissue and fat can reduce breast cancer risk (Table 3) ^[51].

Table 3. Ongoing clinical trials in nanoemulsions ^[52] *.

ClinicalTrial.Gov ID	Active Compound	Nanoemulsion Constituents	Sponsor and Collaborators	Description	Status
NCT02367547	Aminolevulinic Acid	Soy phosphatidyl-choline; propylene glycol	Joint Authority for Päijät-Häme Social and Health Care. Tampere University University of Jyvaskyla.	Superficial basal cell cancer’s photodynamic therapy.	Active, not recruiting
NCT01975363	Curcumin	Data not found	Ohio State University Comprehensive Cancer Center.	Curcumin nanoparticles to modulate pro-inflammatory. Biomarkers in plasma and breast adipose tissue.	Active, not recruiting
NCT03865992	Curcumin	Data not available	City of Hope Medical Center. National Cancer Institute (NCI).	Oral curcumin nanoemulsion for treating joint pain in breast cancer survivors caused by using aromatase inhibitors.	Recruiting

ClinicalTrial.Gov ID

Active Compound

Nanoemulsion Constituents

Sponsor and Collaborators

Description

Status

NCT02367547

Aminolevulinic Acid

Soy phosphatidyl-choline; propylene glycol

Joint Authority for Päijät-Häme Social and Health Care.

Tampere University

University of Jyvaskyla.

Superficial basal cell cancer’s photodynamic therapy.

Active,

not recruiting

NCT01975363

Curcumin

Data not found

Ohio State University Comprehensive Cancer Center.

Curcumin nanoparticles to modulate pro-inflammatory.

Biomarkers in plasma and breast adipose tissue.

Active,

not recruiting

NCT03865992

Curcumin

Data not available

City of Hope Medical Center.

National Cancer Institute (NCI).

Oral curcumin nanoemulsion for treating joint pain in breast cancer survivors caused by using aromatase inhibitors.

Recruiting

* https://clinicaltrials.gov, accessed on 10 February 2023.

References

Schulman, J.H.; Stoeckenius, W.; Prince, L.M. Mechanism of Formation and Structure of Micro Emulsions by Electron Microscopy. J. Phys. Chem. 1959, 63, 1677–1680.
Jin, Y.; Tian, S.; Guo, J.; Ren, X.; Li, X.; Gao, S. Synthesis, Characterization and Exploratory Application of Anionic Surfactant Fatty Acid Methyl Ester Sulfonate from Waste Cooking Oil. J. Surfactants Deterg. 2016, 19, 467–475.
Jaiswal, M.; Dudhe, R.; Sharma, P.K. Nanoemulsion: An advanced mode of drug delivery system. 3 Biotech 2015, 5, 123–127.
McClements, D.J. Nanoemulsions versus microemulsions: Terminology, differences, and similarities. Soft Matter 2012, 8, 1719–1729.
Chen, F.; Liang, L.; Zhang, Z.; Deng, Z.; Decker, E.A.; McClements, D.J. Inhibition of lipid oxidation in nanoemulsions and filled microgels fortified with omega-3 fatty acids using casein as a natural antioxidant. Food Hydrocoll. 2017, 63, 240–248.
Uskoković, V.; Drofenik, M. Synthesis of Materials within Reverse Micelles. Surf. Rev. Lett. 2005, 12, 239–277.
Peng, L.-C.; Liu, C.-H.; Kwan, C.-C.; Huang, K.-F. Optimization of water-in-oil nanoemulsions by mixed surfactants. Colloids Surf. A Physicochem. Eng. Asp. 2010, 370, 136–142.
Leister, N.; Karbstein, H.P. Evaluating the Stability of Double Emulsions—A Review of the Measurement Techniques for the Systematic Investigation of Instability Mechanisms. Colloids Interfaces 2020, 4, 8.
Middelberg, A.P.J.; Dimitrijev-Dwyer, M. A Designed Biosurfactant Protein for Switchable Foam Control. ChemPhysChem 2011, 12, 1426–1429.
Zhao, C.; Dwyer, M.D.; Yu, L.; Middelberg, A.P.J. From Folding to Function: Design of a New Switchable Biosurfactant Protein. ChemPhysChem 2017, 18, 488–492.
Pulko, I.; Krajnc, P. High Internal Phase Emulsion Templating—A Path To Hierarchically Porous Functional Polymers. Macromol. Rapid Commun. 2012, 33, 1731–1746.
Pickering, S.U. CXCVI.—Emulsions. J. Chem. Soc. Trans. 1907, 91, 2001–2021.
Xiao, M.; Xu, A.; Zhang, T.; Hong, L. Tailoring the Wettability of Colloidal Particles for Pickering Emulsions via Surface Modification and Roughness. Front. Chem. 2018, 6, 225.
Yu, H.; Xu, Z.; Chen, X.; Xu, L.; Yin, Q.; Zhang, Z.; Li, Y. Reversal of Lung Cancer Multidrug Resistance by pH-Responsive Micelleplexes Mediating Co-Delivery of siRNA and Paclitaxel: Reversal of Lung Cancer Multidrug Resistance. Macromol. Biosci. 2014, 14, 100–109.
Chen, B.-H.; Huang, R.-F.S.; Wei, Y.-J.; Inbaraj, B.S. Inhibition of colon cancer cell growth by nanoemulsion carrying gold nanoparticles and lycopene. Int. J. Nanomed. 2015, 10, 2823–2846.
Ahsan, H. Family History of Colorectal Adenomatous Polyps and Increased Risk for Colorectal Cancer. Ann. Intern. Med. 1998, 128, 900.
Thiery, J.P.; Sleeman, J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 2006, 7, 131–142.
Mein, J.R.; Lian, F.; Wang, X.-D. Biological activity of lycopene metabolites: Implications for cancer Prevention: Nutrition Reviews©. Nutr. Rev. 2008, 66, 667–683.
Solans, C.; Solé, I. Nano-emulsions: Formation by low-energy methods. Curr. Opin. Colloid Interface Sci. 2012, 17, 246–254.
Lu, W.; Zhang, G.; Zhang, R.; Flores, L.G.; Huang, Q.; Gelovani, J.G.; Li, C. Tumor Site–Specific Silencing of NF-κB p65 by Targeted Hollow Gold Nanosphere–Mediated Photothermal Transfection. Cancer Res. 2010, 70, 3177–3188.
Hu, C.-M.J.; Zhang, L. Nanoparticle-based combination therapy toward overcoming drug resistance in cancer. Biochem. Pharmacol. 2012, 83, 1104–1111.
Abadi, A.V.M.; Karimi, E.; Oskoueian, E.; Mohammad, G.R.K.S.; Shafaei, N. Chemical investigation and screening of anti-cancer potential of Syzygium aromaticum L. bud (clove) essential oil nanoemulsion. 3 Biotech 2022, 12, 49.
Hsu, H.J.; Huang, R.F.; Kao, T.H.; Inbaraj, B.S.; Chen, B.H. Preparation of carotenoid extracts and nanoemulsions from Lycium barbarum L. and their effects on growth of HT-29 colon cancer cells. Nanotechnology 2017, 28, 135103.
Wang, B.; Cai, T.; Liu, Q.; Whitney, J.; Du, M.; Ma, Q.; Zhang, R.; Yang, L.; Cole, S.; Cai, Y. Preparation and evaluation of spirulina polysaccharide nanoemulsions. Int. J. Mol. Med. 2018, 42, 1273–1282.
Khatamian, N.; Tabrizi, M.H.; Ardalan, P.; Yadamani, S.; Maragheh, A.D. Synthesis of Carum Carvi essential oil nanoemulsion, the cytotoxic effect, and expression of caspase 3 gene. J. Food Biochem. 2019, 43, e12956.
Al-Otaibi, W.A.; AlMotwaa, S.M. Oxaliplatin-loaded nanoemulsion containing Teucrium polium L. essential oil induces apoptosis in Colon cancer cell lines through ROS-mediated pathway. Drug Deliv. 2022, 29, 2190–2205.
Alkreathy, H.M.; Alkhatib, M.H.; Al Musaddi, S.A.; Balamash, K.S.A.; Osman, N.N.; Ahmad, A. Enhanced antitumour activity of doxorubicin and simvastatin combination loaded nanoemulsion treatment against a Swiss albino mouse model of Ehrlich ascites carcinoma. Clin. Exp. Pharmacol. Physiol. 2019, 46, 496–505.
Zhang, Z.; Kuo, J.C.-T.; Zhang, C.; Huang, Y.; Zhou, Z.; Lee, R.J. A Squalene-Based Nanoemulsion for Therapeutic Delivery of Resiquimod. Pharmaceutics 2021, 13, 2060.
Enin, H.A.A.; Alquthami, A.F.; Alwagdani, A.M.; Yousef, L.M.; Albuqami, M.S.; Alharthi, M.A.; Alsaab, H.O. Utilizing TPGS for Optimizing Quercetin Nanoemulsion for Colon Cancer Cells Inhibition. Colloids Interfaces 2022, 6, 49.
Ahmad, N.; Albassam, A.A.; Khan, M.F.; Ullah, Z.; Buheazah, T.M.; AlHomoud, H.S.; Al-Nasif, H.A. A novel 5-Fluorocuracil multiple-nanoemulsion used for the enhancement of oral bioavailability in the treatment of colorectal cancer. Saudi J. Biol. Sci. 2022, 29, 3704–3716.
Kotta, S. Formulation of Resveratrol Nanoemulsion by Phase Inversion Technique and Evaluation of Anti-Cancer Activity on Human Colon Cancer Cell Lines. Indian J. Pharm. Educ. Res. 2021, 55, S623–S629.
Patel, R.; Singh, S.K.; Singh, S.; Sheth, N.R.; Gendle, R. Development and characterization of curcumin loaded transfersome for transdermal delivery. J. Pharm. Sci. Res. 2009, 1, 65–71.
Almotwaa, S.M.; Alkhatib, M.H.; Alkreathy, H.M. Incorporating ifosfamide into salvia oil-based nanoemulsion diminishes its nephrotoxicity in mice inoculated with tumor. Bioimpacts 2019, 10, 9–16.
Acharya, S.D.; Tamane, P.K.; Khante, S.N.; Pokharkar, V.B. QbD Based Optimization of Curcumin Nanoemulsion: DoE and Cytotoxicity Studies. Indian J. Pharm. Educ. Res. 2020, 54, 329–336.
Bashlouei, S.G.; Karimi, E.; Zareian, M.; Oskoueian, E.; Shakeri, M. Heracleum persicum Essential Oil Nanoemulsion: A Nanocarrier System for the Delivery of Promising Anticancer and Antioxidant Bioactive Agents. Antioxidants 2022, 11, 831.
Shoorvarzi, S.N.; Shahraki, F.; Shafaei, N.; Karimi, E.; Oskoueian, E. Citrus aurantium L. bloom essential oil nanoemulsion: Synthesis, characterization, cytotoxicity, and its potential health impacts on mice. J. Food Biochem. 2020, 44, e13181.
James, E.E.; Iwao, O.; Botchkina, M.M.; Ivanovna, G. Nanoemulsion Compositions of Taxoid Drugs, and Methods for the Use Thereof to Target Cancer Cells and Cancer Stem Cells. US10206875, February 2019. Available online: https://www.freepatentsonline.com/result.html?sort=relevance&srch=top&query_txt=10206875&submit=&patents_us=on (accessed on 10 February 2023).
Won, L.K.; Sara, Y.L. Hydrogel-Based Nanoemulsion for Selectively Labelling Cancer Lesion, and Preparation Method Therefor United States Seoul National University R&db Foundation. US11103600, 2021. Available online: https://www.freepatentsonline.com/11103600.html (accessed on 10 February 2023).
Thome, K.F.; Paulo, B.S.; Debora, L. Nanoemulsions and Methods for Cancer Therapy United States Fernando Thome Kreutz. US11332494, 2022. Available online: https://www.freepatentsonline.com/11332494.html (accessed on 10 February 2023).
Won, L.K.; Yoon, J.; Sara, L. Nanocarrier for Selective Fluorescence Labeling of Cancer Cell and Preparation Method Therefor United Statesseoul National University R&Db Foundation. US11298428, 2022. Available online: https://www.freepatentsonline.com/11298428.html (accessed on 10 February 2023).
Tayeb, H.H.; Felimban, R.; Hasaballah, N.; Mahfouz, J.B.; Chaudhary, A.; Felemban, M.; Alnadwi, F.; Rizg, W. Essential Oil Nanoemulsion and Methods of Use Thereof United States King Abdulaziz University. US11364199, 2022. Available online: https://www.freepatentsonline.com/11364199.html (accessed on 10 February 2023).
Moira, M.S. Ionic Liquid-Based Nanoemulsion Formulation for the Efficient Delivery of Hydrophilic and Hydrophobic Therapeutic Agents United States Wisconsin Alumni Research Foundation. US11464738, 2022. Available online: https://www.freepatentsonline.com/11464738.html (accessed on 10 February 2023).
Aquilue, S.; Gris, J.L.; Del Carmen, M.; Gañán, D.; Isabel, M. Oil-in-Water Nanoemulsion Composition of Clobetasol United States Laboratorios Salvat, S.A. US10857160, 2020. Available online: https://www.freepatentsonline.com/10857160.html (accessed on 10 February 2023).
Evan, C.U.; Edmund, R.M. Compositions of Fluorocarbon Nanoemulsion, and Methods of Preparation and Use Thereof United States NuvOx Pharma LLC (Tucson, AZ, US). US11304899, 2022. Available online: https://www.freepatentsonline.com/11304899.html (accessed on 10 February 2023).
Congling, Q. Transparent Nanoemulsions Comprising Lauric Oil United States Conopco, Inc. (Trumbull, CT, US). US11266580, 2022. Available online: https://www.freepatentsonline.com/11266580.html (accessed on 10 February 2023).
Christopher, W.S.; Steven, T. Transparent Colloidal Vitamin Supplement Blend United States Quicksilver Scientific, Inc. (Lafayette, CO, US). US11304900, 2022. Available online: https://www.freepatentsonline.com/11304900.html (accessed on 10 February 2023).
Felix, S.J.M.; Nan, S.; Amr, I.A.-F. Magnetic Emulsions as Contrast Agents for Subsurface Applications United States SAUDI ARABIAN OIL COMPANY (Dhahran, SA). US11506049, 2022. Available online: https://www.freepatentsonline.com/11506049.html (accessed on 10 February 2023).
Amit, K.; Steven, R.; Malcolm, D.; Jesse, E.; Darrick, C.; Bryan, J.B. Compositions and Methods for Delivery of RNA United States HDT Bio Corp. (Seattle, WA, USA). Available online: https://www.freepatentsonline.com/11534497.htmlus11534497 (accessed on 10 February 2023).
Amit, K.; Duthie, R.S.; Erasmus, M.; Carter, J.; Bryan, B.; Seattle, J. RNA-Lipid Nanoparticle Complexes of Viral RNA Polymerase Region and SARS-CoV-2 Spike Protein Region United States HDT Bio Corp (Seattle, WA, US). US11376335, 2022. Available online: https://www.freepatentsonline.com/11376335.html (accessed on 10 February 2023).
Luan, L.; Chi, Z.; Liu, C. Chinese White Wax Solid Lipid Nanoparticles as a Novel Nanocarrier of Curcumin for Inhibiting the Formation of Staphylococcus aureus Biofilms. Nanomaterials 2019, 9, 763.
Aljabri, N.M.; Shi, N.; Cavazos, A. Nanoemulsion: An emerging technology for oilfield applications between limitations and potentials. J. Pet. Sci. Eng. 2021, 208, 109306.
Available online: https://clinicaltrials.gov (accessed on 12 February 2023).

© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.

Upload a video for this entry

Information

Subjects: Pharmacology & Pharmacy

Contributors MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :

Ramdas Pandhare

Bhupendra G. Prajapati

View Times: 301

Update Date: 14 Aug 2023

Table of Contents

Video Upload Options

Confirm